Latteri M A, Cipolla C, Gebbia V, Lampasona G, Amato C, Gebbia N
Department of Anatomy and Surgery, University of Palermo, Italy.
Eur J Surg Oncol. 1995 Aug;21(4):432-4. doi: 10.1016/s0748-7983(95)92945-2.
The authors describe one case of a rare primitive non-Hodgkin lymphoma of the uterus, and two cases of primary non-Hodgkin lymphoma of the breast. Histologically, the uterine lymphoma, although clinically confined to the uterus, was a diffuse large cell lymphoma, group G according to the Working formulation for Clinical Usage. The two cases of breast lymphoma were a centrocytic-centroblastic and a lymphoplasmocytoid non-Hodgkin lymphoma, respectively. All cases were initially treated with radical surgery plus radiotherapy, but the first patient showed an early recurrence at distant sites, which required systemic cytotoxic chemotherapy. The patient with uterine non-Hodgkin lymphoma received a very intense regimen--i.e. the ProMACE-Cytabom--because of the unfavourable histology, while the two patients with primary breast non-Hodgkin lymphoma received less aggressive CHOP and CVP chemotherapy. All patients are still alive and free of disease 3 to 6 years after initial diagnosis. These cases stress the systemic nature of non-Hodgkin lymphomas even if apparently localized to a single extranodal organ. Thus, although a definitive therapeutic strategy cannot be drawn from the rare and occasional reports in the medical literature, primary extranodal lymphomas require integrated multimodality therapy with radiotherapy and/or chemotherapy.
作者描述了一例罕见的子宫原发性非霍奇金淋巴瘤以及两例乳腺原发性非霍奇金淋巴瘤。组织学上,子宫淋巴瘤尽管临床局限于子宫,但为弥漫性大细胞淋巴瘤,根据临床应用工作分类法属于G组。两例乳腺淋巴瘤分别为中心细胞 - 中心母细胞型和淋巴浆细胞样非霍奇金淋巴瘤。所有病例最初均接受根治性手术加放疗,但首例患者出现远处早期复发,这需要进行全身细胞毒性化疗。子宫非霍奇金淋巴瘤患者因组织学表现不佳接受了非常强烈的化疗方案,即ProMACE - Cytabom方案,而两例乳腺原发性非霍奇金淋巴瘤患者接受了强度较低的CHOP和CVP化疗。所有患者在初次诊断后3至6年仍存活且无疾病。这些病例强调了非霍奇金淋巴瘤的系统性,即使其明显局限于单个结外器官。因此,尽管无法从医学文献中罕见且偶然的报告得出明确的治疗策略,但原发性结外淋巴瘤需要放疗和/或化疗的综合多模式治疗。